ATRX expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.554410E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.819200E-01
Normal-vs-Stage2
1.480040E-01
Normal-vs-Stage3
1.564790E-01
Normal-vs-Stage4
8.696800E-01
Stage1-vs-Stage2
4.582000E-01
Stage1-vs-Stage3
1.779620E-02
Stage1-vs-Stage4
2.660800E-01
Stage2-vs-Stage3
1.420750E-03
Stage2-vs-Stage4
4.900300E-02
Stage3-vs-Stage4
7.604000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.404390E-01
Normal-vs-AfricanAmerican
6.471000E-01
Normal-vs-Asian
9.352400E-02
Caucasian-vs-AfricanAmerican
2.575600E-01
Caucasian-vs-Asian
3.063600E-01
AfricanAmerican-vs-Asian
1.455200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.359570E-01
Normal-vs-Female
2.015200E-01
Male-vs-Female
6.585600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.196800E-01
Normal-vs-Age(41-60Yrs)
4.389400E-01
Normal-vs-Age(61-80Yrs)
8.453800E-02
Normal-vs-Age(81-100Yrs)
2.296400E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.890600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.579610E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.248240E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.368000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.523400E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.620200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.630300E-02
Normal-vs-Daily Drinker
4.420100E-02
Normal-vs-Weekly Drinker
1.323180E-01
Normal-vs-Occasional Drinker
4.710200E-01
Normal-vs-Social Drinker
5.584800E-01
Non Drinker-vs-Daily Drinker
4.033400E-01
Non Drinker-vs-Weekly Drinker
9.765400E-01
Non Drinker-vs-Occasional Drinker
2.872100E-02
Non Drinker-vs-Social Drinker
2.285000E-01
Daily Drinker-vs-Weekly Drinker
5.459800E-01
Daily Drinker-vs-Occasional Drinker
1.845880E-02
Daily Drinker-vs-Social Drinker
1.204570E-01
Weekly Drinker-vs-Occasional Drinker
1.324770E-01
Weekly Drinker-vs-Social Drinker
3.036400E-01
Occasional Drinker-vs-Social Drinker
8.814400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.003600E-02
Normal-vs-Grade 2
1.421760E-02
Normal-vs-Grade 3
1.114030E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.425600E-01
Grade 1-vs-Grade 3
4.749800E-01
Grade 1-vs-Grade 4
4.003600E-02
Grade 2-vs-Grade 3
4.574600E-01
Grade 2-vs-Grade 4
1.421760E-02
Grade 3-vs-Grade 4
1.114030E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.351900E-02
Normal-vs-NonDiabetic
1.123970E-01
Diabetic-vs-NonDiabetic
7.056600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.095200E-01
Normal-vs-NoPancreatitis
1.301170E-01
Pancreatitis-vs-NoPancreatitis
2.501800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.930990E-01
Normal-vs-N1
1.608800E-01
N0-vs-N1
9.833600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.277200E-01
Normal-vs-TP53-NonMutant
3.840200E-01
TP53-Mutant-vs-TP53-NonMutant
7.726400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
